BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,599,419 | +3.9% | 651,813 | +25.4% | 0.02% | +12.5% |
| Q2 2023 | $23,675,185 | -72.5% | 519,648 | -75.5% | 0.02% | -73.3% |
| Q1 2023 | $86,063,863 | +165.3% | 2,121,890 | +233.3% | 0.06% | +140.0% |
| Q4 2022 | $32,445,973 | -23.2% | 636,570 | -18.9% | 0.02% | -16.7% |
| Q3 2022 | $42,255,000 | +36.3% | 784,528 | +62.6% | 0.03% | +30.4% |
| Q2 2022 | $30,999,000 | -36.6% | 482,602 | -23.5% | 0.02% | -23.3% |
| Q1 2022 | $48,912,000 | +11.4% | 630,802 | +23.3% | 0.03% | +25.0% |
| Q4 2021 | $43,905,000 | -10.4% | 511,474 | -16.1% | 0.02% | -17.2% |
| Q3 2021 | $49,008,000 | -4.0% | 609,327 | -3.9% | 0.03% | -6.5% |
| Q2 2021 | $51,051,000 | -0.8% | 634,181 | +4.0% | 0.03% | -6.1% |
| Q1 2021 | $51,444,000 | -11.3% | 609,970 | -15.7% | 0.03% | -5.7% |
| Q4 2020 | $58,025,000 | -10.1% | 723,151 | -9.9% | 0.04% | -16.7% |
| Q3 2020 | $64,532,000 | +5.8% | 802,440 | +13.3% | 0.04% | -10.6% |
| Q2 2020 | $60,966,000 | +1.1% | 708,087 | -4.7% | 0.05% | -14.5% |
| Q1 2020 | $60,296,000 | -24.0% | 742,649 | -21.7% | 0.06% | -3.5% |
| Q4 2019 | $79,288,000 | -7.0% | 948,203 | -2.8% | 0.06% | -16.2% |
| Q3 2019 | $85,288,000 | -34.1% | 975,050 | -38.3% | 0.07% | -34.6% |
| Q2 2019 | $129,429,000 | +55.5% | 1,580,326 | +54.4% | 0.10% | +31.6% |
| Q1 2019 | $83,240,000 | +88.0% | 1,023,727 | +52.2% | 0.08% | +79.5% |
| Q4 2018 | $44,272,000 | -22.1% | 672,620 | -8.8% | 0.04% | -12.0% |
| Q3 2018 | $56,842,000 | +108.9% | 737,343 | +100.0% | 0.05% | +108.3% |
| Q2 2018 | $27,216,000 | -55.2% | 368,594 | -60.5% | 0.02% | -52.0% |
| Q1 2018 | $60,701,000 | +19.6% | 933,291 | +18.9% | 0.05% | +22.0% |
| Q4 2017 | $50,753,000 | +9.4% | 785,162 | +6.2% | 0.04% | +7.9% |
| Q3 2017 | $46,392,000 | +37.4% | 739,318 | +32.5% | 0.04% | +22.6% |
| Q2 2017 | $33,775,000 | +68.6% | 557,902 | +44.4% | 0.03% | +72.2% |
| Q1 2017 | $20,030,000 | -55.4% | 386,264 | -61.9% | 0.02% | -56.1% |
| Q4 2016 | $44,927,000 | -27.0% | 1,013,264 | -21.6% | 0.04% | -29.3% |
| Q3 2016 | $61,520,000 | -54.6% | 1,292,453 | -56.8% | 0.06% | -58.0% |
| Q2 2016 | $135,386,000 | -42.6% | 2,993,928 | -47.9% | 0.14% | -47.9% |
| Q1 2016 | $235,938,000 | +368.7% | 5,743,418 | +335.2% | 0.26% | +430.0% |
| Q4 2015 | $50,344,000 | +177.6% | 1,319,634 | +139.1% | 0.05% | +194.1% |
| Q3 2015 | $18,134,000 | -59.8% | 552,006 | -14.5% | 0.02% | -57.5% |
| Q2 2015 | $45,150,000 | -43.2% | 645,626 | -44.4% | 0.04% | -48.1% |
| Q1 2015 | $79,557,000 | +16.7% | 1,161,413 | +24.8% | 0.08% | +26.2% |
| Q4 2014 | $68,191,000 | -25.9% | 930,416 | -27.4% | 0.06% | -24.7% |
| Q3 2014 | $92,019,000 | +20.5% | 1,282,146 | +21.4% | 0.08% | +11.0% |
| Q2 2014 | $76,361,000 | +7.3% | 1,056,162 | +9.2% | 0.07% | 0.0% |
| Q1 2014 | $71,184,000 | +30.0% | 967,445 | +22.9% | 0.07% | +46.0% |
| Q4 2013 | $54,770,000 | +11.5% | 787,474 | +5.3% | 0.05% | +8.7% |
| Q3 2013 | $49,139,000 | -44.4% | 748,050 | -41.4% | 0.05% | -47.1% |
| Q2 2013 | $88,386,000 | – | 1,275,962 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |